| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/2005 | CN1610545A Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 04/27/2005 | CN1610544A Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | CN1610543A Use of N, N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1610541A Novel chromium (III) alpha amino acid complexes |
| 04/27/2005 | CN1610540A Methods and apparatus for improved administration of analgesics |
| 04/27/2005 | CN1610539A Pharmaceutical composition comprising a 5HT1 receptor agonist |
| 04/27/2005 | CN1610536A Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis |
| 04/27/2005 | CN1609114A Notoginseng leaf total flavone and its prepn and application |
| 04/27/2005 | CN1609113A Effective cowberry part for treating respiratory tract disease and its prepn process |
| 04/27/2005 | CN1609105A 1-methylolimidazole [1, 2-alpha] quinoxaline compound and its application |
| 04/27/2005 | CN1609086A MPTP affinity labels |
| 04/27/2005 | CN1608669A Filming aerosol for treating tinea coporis, tinea manuum and tinea pedis |
| 04/27/2005 | CN1608649A Chinese medicine health tonic for raising antisenility capacity and improving memory |
| 04/27/2005 | CN1608629A Compound panoxatriol saponin with physiological activity and its prepn and use |
| 04/27/2005 | CN1608628A Application of stevioside R1 and its derivative as medicine for preventing and treating neurodegeneration disease |
| 04/27/2005 | CN1608627A SARS preventing medicine |
| 04/27/2005 | CN1608626A Fosphenytoin sodium powder for injection and its prepn |
| 04/27/2005 | CN1608625A Use and medicine of 4-dedimethylamino tetracycline and its derivative in treating skin diseases |
| 04/27/2005 | CN1608624A Cefpoxime proxetil for clinical injection |
| 04/27/2005 | CN1608623A Enteric coated donepezil hydrochloride tablet and its perpn process |
| 04/27/2005 | CN1608622A Solid dispersed Nimoldipine tablet and its prepn process |
| 04/27/2005 | CN1608621A Fine bicyclic alcohol powder and oral bicyclic alcohol release controlling prepn |
| 04/27/2005 | CN1608620A Solid bicyclic alcohol dispersion |
| 04/27/2005 | CN1608619A Medicine recipe with baicalin |
| 04/27/2005 | CN1608618A Veterinary medicine injection containing chlorocyaniosaliamine or its sodium salt |
| 04/27/2005 | CN1608617A Application of levocarnitine and its derivative in preventing and treating high altitude diseases |
| 04/27/2005 | CN1608616A Application of coniferyl ferulate in anticancer medicine |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608614A New slimming effervescent tablet form |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198940C Fermentation of clavulanic acid at a controlled level of ammonia |
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198839C Novel dipeptide amidines as thrombin inhibitors |
| 04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/27/2005 | CN1198833C Vinyl pyrrolidone cephlosporins with basic substitutent group |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198827C Selected derivatives of K-252a |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198824C Polymorphs of N-methyl-N-(3-3-{2-thienylcarbonyl]-pyrazol -[1,5-alpha]-pyrimidin-7-yl}phenyl)a cetamide and compositions and methods related thereton |
| 04/27/2005 | CN1198821C Process for preparation of sulfonamide derivs. and crystals thereof |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198816C Farnesyl protein transferase inhibitors |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198808C Use of benzotriazole UV absorbers |
| 04/27/2005 | CN1198807C 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198799C Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyloxy phenyl}ethoxy)phenyl] propanoic acid |
| 04/27/2005 | CN1198793C Ethers of methyl venlafaxine |
| 04/27/2005 | CN1198656C Dual action 2', 5'-oligoadenylate antiviral derivatives and uses thereof |
| 04/27/2005 | CN1198655C Solid mixtures of cyclodextrins prep. via melt-extrusion |
| 04/27/2005 | CN1198654C Pharmaceutical complex |
| 04/27/2005 | CN1198653C Preparations for preventing bile acid diarrhea |
| 04/27/2005 | CN1198651C Composition comprising tramadol material and anticonvulsant drug |
| 04/27/2005 | CN1198650C Ocular tension lowering composition for topical administration |
| 04/27/2005 | CN1198649C Drug composition containing PGD2 antagonists for curing inhibitor |
| 04/27/2005 | CN1198635C Chinese medicine haemorrhoids ointment |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198624C Oligosaccharide mixture |
| 04/27/2005 | CN1198623C Ciclesonide-containing aqueous pharmaceutical composition |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/27/2005 | CN1198620C Clathrates of dehydroepindrosterone and corresponding pharmaceutical compositions |
| 04/27/2005 | CN1198619C Application of benzoaza-N-acetic acid derivative in preparation of medicine for treating pulmonary hypertension |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198617C Remedies for cardiac dilastolit disorders |
| 04/27/2005 | CN1198616C Oral formulations for anti-tumor compounds |
| 04/27/2005 | CN1198615C Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198612C Use of imidazo [1, 2-a] pyridine -3 -acetamide derivs. for therapeutic treatment of neuropsychiatric syndromes associated with disfunction of neural circuits of basal ganglia |
| 04/27/2005 | CN1198611C Anti-bacterial medicinal compositions |
| 04/27/2005 | CN1198610C Treatment of neurotic disorders |
| 04/27/2005 | CN1198609C Use of taxiol stabilized by albumin in preparing medicine for treating body tumor and medicine obtained therefrom |
| 04/27/2005 | CN1198608C Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/27/2005 | CN1198606C Benzoyl urea derivatrives injectable preparation and preparing method and their use |
| 04/27/2005 | CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 04/27/2005 | CN1198604C Application of 1-heptanol in preparing medicine for acute and chronic cerebrovascular spasm |
| 04/27/2005 | CN1198598C Hydrophilic/lipophilic polymeric matrix dosage |
| 04/27/2005 | CN1198597C Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor |
| 04/27/2005 | CN1198596C Sustained release formulations for 24 hours release of metoprolol |
| 04/27/2005 | CN1198595C Process for preparation of spraying granule of ovoflaving |
| 04/27/2005 | CN1198594C Therapeutically active compositions |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/27/2005 | CN1198591C Bioenhanced formulations comprising eprosartan in oral dosage form |
| 04/27/2005 | CN1198590C Antibody and polyalkylene glycol-bonded liposome |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/27/2005 | CN1198588C Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
| 04/27/2005 | CN1198586C Topical compositions for NSAI drug delivery |
| 04/27/2005 | CN1198583C Milling process for production of finely milled medicinal substances |
| 04/27/2005 | CN1198576C Skin care compositions contg. combination of skin care actives |
| 04/27/2005 | CN1198563C Acidified composition for topical treatment of nail and skin conditions |